IDEAYA Biosciences, Inc. — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
IDEAYA's board amended the 2023 Employment Inducement Award Plan effective August 19, 2026, increasing the maximum shares available for awards from an unspecified prior level to 7,000,000 shares. The filing does not disclose the prior share authorization or current usage. This expansion permits grants of equity compensation to employees and new hires.
Why this rating
7M shares at ~$1.8B market cap ≈ 0.4% of enterprise value; routine equity plan management, no transaction or business change disclosed.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.